LivaNova (LIVN) EPS (Basic) Growth (1y) (2015 - 2026)
LivaNova (LIVN) EPS (Basic) Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.11 Bn | 194.51 Bn | 7.27 Bn | -47.75% |
| 2 | Stryker | 129.85 Bn | 126.37 Bn | 4.50 Bn | 43.85% |
| 3 | Medtronic | 119.93 Bn | 110.71 Bn | 6.41 Bn | 18.90% |
| 4 | Boston Scientific | 74.18 Bn | 73.64 Bn | 3.85 Bn | 14.55% |
| 5 | Edwards Lifesciences | 52.54 Bn | 48.29 Bn | 1.35 Bn | -25.84% |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 42.13% |
| 7 | GE HealthCare Technologies | 34.25 Bn | 32.14 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.45 Bn | 23.13 Bn | 4.55 Bn | 72.17% |
| 9 | Steris | 23.29 Bn | 22.80 Bn | 684.20 Mn | 13.85% |
| 10 | LivaNova | 4.33 Bn | 3.81 Bn | 273.67 Mn | 297.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 297.16% |
| Mar 31, 2026 | 107.04% |
| Dec 31, 2025 | -45.00% |
| Sep 30, 2025 | -19.00% |
| Jun 30, 2025 | 65.02% |
| Mar 31, 2025 | -674.91% |
| Dec 31, 2024 | 239.82% |
| Sep 30, 2024 | 548.75% |
| Jun 30, 2024 | 1,272.00% |
| Mar 31, 2024 | -662.57% |
| Dec 31, 2023 | 859.43% |
| Sep 30, 2023 | 93.27% |
| Jun 30, 2023 | -92.86% |
| Mar 31, 2023 | 142.52% |
| Dec 31, 2020 | -364.98% |
| Dec 31, 2019 | 118.35% |
| Jun 30, 2019 | 104.00% |
| Dec 31, 2018 | 98.74% |
| Sep 30, 2018 | -209.88% |
| Jun 30, 2018 | -343.54% |